BYD outsells Tesla for the first time in Europe in April

Chinese electric vehicle manufacturer and the world’s largest EV major BYD is going from strength to strength. In April 2025, BYD outsold Tesla in Europe for the first time, an achievement made even more remarkable when viewing PHEV and BEV volumes separately. According to JATO Dynamics’ data, BYD registered 7,231 BEVs in Europe last month,… Continue reading BYD outsells Tesla for the first time in Europe in April

BYD outsells Tesla for the first time in Europe in April

Chinese electric vehicle manufacturer and the world’s largest EV major BYD is going from strength to strength. In April 2025, BYD outsold Tesla in Europe for the first time, an achievement made even more remarkable when viewing PHEV and BEV volumes separately. According to JATO Dynamics’ data, BYD registered 7,231 BEVs in Europe last month,… Continue reading BYD outsells Tesla for the first time in Europe in April

INDY 500 Stars Join Forces with ZERO Prostate Cancer to Put Veterans’ Health in the Spotlight at Memorial Day Weekend Races

INDIANAPOLIS, May 23, 2025 /PRNewswire/ — This Memorial Day Weekend, the spotlight won’t only be on speed—it’ll be on saving lives. ZERO Prostate Cancer (ZERO), the nation’s leading advocacy and support organization for prostate cancer, is proud to announce its powerful presence across America’s most iconic motorsports stages: the Indianapolis 500 and NASCAR’s Coca-Cola 600 and BetMGM… Continue reading INDY 500 Stars Join Forces with ZERO Prostate Cancer to Put Veterans’ Health in the Spotlight at Memorial Day Weekend Races

Celltrion’s YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Celltrion previously received interchangeability (IC) designation for YUFLYMA® (adalimumab-aaty) in prefilled syringes (20mg & 80mg); Expanded interchangeability (IC) designation applies to prefilled syringe (40mg) and autoinjectors (40mg and 80mg) INCHEON, South Korea, May 23, 2025 /PRNewswire/ — Celltrion, Inc. today announced that… Continue reading Celltrion’s YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths

Peugeot e-5008

We will start at the back of the e-5008, because it’s the space and versatility that’s really going to sell this car. The boot release is hidden in an inconveniently small crevice in between the bootlid and bumper, which can make your fingers very mucky when you’re opening the boot. Inside, though, it’s a happier… Continue reading Peugeot e-5008

The concern of Stellantis employees: “If Qatar buys the land, they will not leave a piece of factory in front of a 4 -star hotel”

The site of the Stellantis factory in Poissy in the Yvelines is one of the Île-de-France sites in the running for the future PSG stadium. The unions redouble their concern for the future of their factory and call on employees to demonstrate on Monday in Poissy. Most of the day: our exclusive selection Every day,… Continue reading The concern of Stellantis employees: “If Qatar buys the land, they will not leave a piece of factory in front of a 4 -star hotel”